The Human Medicines (Amendment) Regulations 2017

Amendment of Regulation 8 (general interpretation)

3.—(1) Regulation 8(1) is amended as follows.

(2) In paragraph (1)—

(a) in the appropriate place insert—

““external use” in relation to a medicinal product—

(a)

means its use by application to the skin, teeth, mucosa of the mouth, throat, nose, ear, eye, vagina or anal canal in circumstances where local action only is necessary and systemic absorption is unlikely to occur; but

(b)

does not include its use by means of a throat spray, nasal spray, nasal inhalation or teething preparation or by means of throat pastilles, throat lozenges, throat tablets or nasal drops;”; and

(b) in the definition of “the relevant register”, in paragraph (d)—

(i) after “a physiotherapist” insert “, an orthoptist”;

(ii) in sub-paragraph (ii) omit “or”; and

(iii) after sub-paragraph (iii) insert—

“, or

(iv) orthoptists;”.

(1)

Regulation 8 has been previously amended by S.I. 2013/1855 and 2593, 2015/354 and 2016/186, 190 and 696